new glp-1 medications Agonists: A Comprehensive Overview MCT2D | The Benefits of

A variety of iron chelators have received approval for the management of iron overload and the associated organ damage resulting from secondary hemochromatosis

Overall, compared with the large and growing amount of pre-clinical and mechanistic evidence highlighting the reward-modulating and thus potentially anti-addictive properties of GLP-1RAs, only a few studies have investigated thus far the potential use of these medications in clinical populations with alcohol- or other substance-use disorders

Helping you achieve our cult famous healthy GLOW

10.3389/fmicb.2023.1088187 128 YoonH

Noriega-Guerra H, Freitas VM

Discussion No questions have been added yet